Chronic Disease Burden in Thailand Reaches 1.6 Trillion Baht Annually
The Pharmaceutical Research and Manufacturers Association (PReMA) reports that rising rates of diabetes, hypertension, and related complications are placing a significant economic burden on Thailand.
According to a report from Matichon Online citing the Pharmaceutical Research and Manufacturers Association (PReMA), Thailand is facing a critical challenge regarding the prevalence of chronic non-communicable diseases. Data indicates that conditions such as diabetes, hypertension, and subsequent heart and kidney diseases are on the rise across the population. PReMA estimates that the economic impact of managing these health issues has reached approximately 1.6 trillion baht per year. For residents and long-term expatriates, this trend highlights the increasing pressure on the national healthcare infrastructure and the importance of proactive health management. While the report underscores the scale of the financial and social burden, it does not detail specific government policy shifts or immediate changes to public health access. Travelers and residents should remain aware that while Thailand offers high-quality medical facilities, the rising demand for chronic care may influence future healthcare costs and resource availability. Further confirmation is needed regarding how the government intends to address these long-term fiscal and public health challenges.
